MRZM
MARIZYME, INC.Company Information
- Company Name
- MARIZYME, INC.
- CIK
- CIK0001413754
- Category
- Non-accelerated filer<br>Smaller reporting company
- Ticker: Exchange
- MRZM: OTC
- Fiscal Year End
- December 31
- Owner Organization
- 08 Industrial Applications and Services
- SIC
- 3841
- SIC Description
- Surgical & Medical Instruments & Apparatus
- Ticker
- MRZM
SEC filing data through
Insider Sentiment
- Last purchase
- 2023-08-29
- Last sale
- 2023-08-29
- Shares purchased (TTM)
- 105,000
- Shares sold (TTM)
- 105,000
Institutional Sentiment
- As of
- —
- Institutional shares owned
- —
- Shares outstanding
- —
- Ownership
- —
Earnings Market Reaction
- Filing date
- 2025-03-05
- Price on filing date
- —
- 1-month reaction
- -83.80%
- 3-month reaction
- -99.40%
Balance Sheet
Values in millions ($)| Line item | 2024-09-30 | 2024-06-30 | 2024-03-31 | 2023-12-31 | 2023-09-30 | 2023-06-30 | 2023-03-31 | 2022-12-31 | 2022-09-30 | 2022-06-30 | 2022-03-31 | 2021-12-31 | Subscriber-only column | Subscriber-only column | Subscriber-only column | Subscriber-only column | Subscriber-only column | Trend |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Assets | ||||||||||||||||||
| Cash | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 1 | 1 | 2 | 3 | 4 | ||||||
| Accounts Receivable Net Current | 0 | - | - | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | ||||||
| Other Receivables | - | - | - | - | - | - | - | - | 0 | 0 | 0 | - | ||||||
Assets Current | ||||||||||||||||||
| Assets Current | 1 | 1 | 1 | 1 | 1 | 1 | 2 | 2 | 2 | 3 | 4 | 4 | ||||||
| Accounts And Other Receivables Net Current | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | - | - | - | 0 | ||||||
| Prepaid Expense Current | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 0 | 0 | 0 | ||||||
| Inventory Net | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | ||||||
| Property Plant And Equipment Net | - | - | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | ||||||
Assets Noncurrent | ||||||||||||||||||
| Assets Noncurrent | 20 | 21 | 21 | 21 | 36 | 36 | 36 | 37 | 61 | 62 | 61 | 62 | ||||||
| Operating Lease Right Of Use Asset | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 2 | 2 | 1 | 1 | ||||||
| Intangible Assets Net Excluding Goodwill | - | - | - | - | - | - | 27 | 28 | 52 | 52 | 53 | 53 | ||||||
| Deposits Assets Noncurrent | - | - | - | - | - | - | - | - | 0 | 0 | 0 | - | ||||||
| Finite Lived Intangible Assets Net | 14 | 14 | 14 | 14 | 27 | 27 | - | 28 | - | - | - | - | ||||||
| Prepaid Expense Other Noncurrent | - | - | - | 0 | 0 | - | - | 0 | - | - | - | - | ||||||
| Prepaid Expense Noncurrent | 0 | 0 | 0 | - | - | - | - | - | - | - | - | - | ||||||
| Deposit Assets | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | - | - | - | 0 | ||||||
| Goodwill | 5 | 5 | 5 | 5 | 7 | 7 | 7 | 7 | 7 | 7 | 7 | 7 | ||||||
| Assets | 21 | 22 | 22 | 22 | 37 | 37 | 38 | 39 | 64 | 64 | 65 | 66 | ||||||
Liabilities And Stockholders Equity | ||||||||||||||||||
| Accounts Payable And Accrued Liabilities Current | 3 | 3 | 3 | 2 | 2 | 2 | 2 | 1 | 1 | 1 | 1 | 2 | ||||||
| Notes Payable Current | 3 | 2 | 1 | 1 | 0 | 0 | 2 | 1 | 0 | 0 | 0 | 0 | ||||||
Liabilities Current | ||||||||||||||||||
| Liabilities Current | 30 | 24 | 26 | 23 | 49 | 21 | 8 | 3 | 2 | 2 | 2 | 3 | ||||||
| Due To Related Parties Current | - | - | - | - | - | - | - | - | 0 | 0 | 0 | 1 | ||||||
| Other Liabilities Current | - | - | - | - | - | - | 0 | - | - | - | - | - | ||||||
| Convertible Debt Current | 17 | 17 | 16 | 16 | 19 | 12 | 4 | - | - | - | - | - | ||||||
| Derivative Liabilities Current | - | - | - | - | 26 | 5 | - | - | - | - | - | - | ||||||
| Operating Lease Liability Current | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | ||||||
| Operating Lease Liability Noncurrent | 0 | 0 | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 1 | ||||||
Liabilities Noncurrent | ||||||||||||||||||
| Liabilities Noncurrent | 7 | 7 | 7 | 6 | 10 | 9 | 15 | 18 | 21 | 21 | 18 | 15 | ||||||
| Long Term Notes Payable | - | - | - | - | - | - | - | - | - | - | - | 0 | ||||||
| Derivative Liabilities Noncurrent | - | - | - | - | - | - | 5 | 5 | 5 | 4 | 4 | 2 | ||||||
| Convertible Debt Noncurrent | - | - | - | - | 0 | 0 | - | 3 | 2 | 1 | 0 | - | ||||||
| Contingent Consideration Classified As Equity Fair Value Disclosure | 5 | 6 | 6 | - | - | - | - | - | - | - | - | - | ||||||
| Liabilities | 37 | 31 | 32 | 29 | 59 | 30 | 23 | 21 | 23 | 23 | 20 | 18 | ||||||
| Common Stock Value | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | ||||||
| Additional Paid In Capital | 155 | 152 | 147 | 149 | 120 | 116 | 104 | 103 | 103 | 102 | 99 | 95 | ||||||
| Retained Earnings Accumulated Deficit | -170 | -162 | -158 | -156 | -142 | -109 | -89 | -86 | -62 | -61 | -54 | -48 | ||||||
| Stockholders Equity | -16 | -9 | -11 | -7 | -29 | 7 | 15 | 17 | 41 | 41 | 45 | 48 | ||||||
| Liabilities And Stockholders Equity | 21 | 22 | 22 | 22 | 37 | 37 | 38 | 39 | 64 | 64 | 65 | 66 | ||||||
| Preferred Stock Par Or Stated Value Per Share | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | ||||||
| Preferred Stock Shares Authorized | 25 | 25 | 25 | 25 | 25 | 25 | 25 | 25 | 25 | 25 | 25 | 25 | ||||||
| Preferred Stock Shares Issued | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | ||||||
| Preferred Stock Shares Outstanding | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | ||||||
| Common Stock Par Or Stated Value Per Share | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | ||||||
| Common Stock Shares Authorized | 2,000 | 2,000 | 2,000 | 2,000 | 2,000 | 300 | 300 | 2,000 | 75 | 75 | 75 | 75 | ||||||
| Common Stock Shares Issued | 132 | 132 | 132 | 132 | 47 | 45 | 41 | 41 | 41 | 41 | 41 | 41 | ||||||
| Shares Outstanding | 132 | 132 | 132 | 132 | 47 | 45 | 41 | 41 | 41 | 41 | 41 | 41 | ||||||
Select a line item above to chart it.
Recent filings
- 10-QFiled
- 10-QFiled
- 10-QFiled
- 10-KFiled
- 10-QFiled
- 10-QFiled
- 10-QFiled
- 10-KFiled
- 10-QFiled
- 10-QFiled
- 10-QFiled
- 10-KFiled
Financial statements beyond 3 years are for subscribers only.
Unlock 17+ years of income statements, balance sheets, and cash flow statements
Start 7-day free trialMARIZYME, INC. (MRZM) — SEC Financial Statements & Analysis
MARIZYME, INC. (MRZM) is a surgical & medical instruments & apparatus company, incorporated in NV. MARIZYME, INC. trades on OTC as: MRZM. MARIZYME, INC. (MRZM)'s most recent SEC filing is a Form 10-Q for the period ended 2024-09-30, filed with the SEC on 2025-03-05. Based on that filing, MARIZYME, INC. carries a market cap of $6.58M, a P/E ratio of -0.20x, a P/B ratio of -0.42x, a P/S ratio of 13.24x, an enterprise value of $25.96M, and an EV/EBITDA multiple of -1.00x. On profitability, it posts a gross margin of 71.17%, an operating margin of -5352.51%, a net margin of -6461.17%, a Return on Equity (ROE) of 142.95%, a Return on Assets (ROA) of -110.42%, and a Return on Invested Capital (ROIC) of -206.49%. Per share, it reports EPS of $-0.24, diluted EPS of $-0.24, free cash flow per share of $-0.03, and a dividend per share of $0.00. Over the trailing year, it posted revenue growth of 24.03% year-over-year, net income growth of -56.14% year-over-year, and EPS growth of -84.76% year-over-year. On the balance sheet, it maintains a current ratio of 0.03x, a quick ratio of 0.00x, working capital of $-29.12M, a debt-to-equity ratio of -2.37x, a debt ratio of 1.73, an interest coverage ratio of -2388.68x, free cash flow of $-3.74M (TTM), and net debt of $19.37M. Figures sourced from SEC EDGAR.
- Market Cap
- $6.58M
- P/E TTM
- -0.20x
- EPS TTM
- $-0.24
- P/B TTM
- -0.42x
- ROE TTM
- 142.95%
- ROA TTM
- -110.42%
- Debt To Equity
- -2.37x
- Free Cash Flow TTM
- $-3.74M
- Net Revenue TTM Growth 1Y
- 24.03%
Data as of 2024-09-30 · Source: SEC EDGAR
Frequently Asked Questions
What industry is MARIZYME, INC. in?
MARIZYME, INC. (MRZM) operates in the Surgical & Medical Instruments & Apparatus industry.
What exchange does MRZM trade on?
MARIZYME, INC. (MRZM) trades on the OTC.
Where is MARIZYME, INC. incorporated?
MARIZYME, INC. is incorporated in NV.
When was MARIZYME, INC. (MRZM)'s most recent SEC filing?
MARIZYME, INC. (MRZM)'s most recent SEC filing is a Form 10-Q for the period ended 2024-09-30, filed with the SEC on 2025-03-05.
What is MRZM's market cap?
MARIZYME, INC. (MRZM) has a market capitalization of $6.58M as of 2024-09-30.
What is MRZM's EPS (earnings per share)?
MARIZYME, INC. (MRZM)'s trailing twelve month EPS is $-0.24 as of 2024-09-30.
What is MRZM's ROE (return on equity)?
MARIZYME, INC. (MRZM)'s trailing twelve month Return on Equity (ROE) is 142.95% as of 2024-09-30.
What is MRZM's ROA (return on assets)?
MARIZYME, INC. (MRZM)'s trailing twelve month Return on Assets (ROA) is -110.42% as of 2024-09-30.
What is MRZM's ROIC (return on invested capital)?
MARIZYME, INC. (MRZM)'s trailing twelve month Return on Invested Capital (ROIC) is -206.49% as of 2024-06-30.
What is MRZM's EV/EBITDA?
MARIZYME, INC. (MRZM)'s trailing twelve month EV/EBITDA is -1.00x as of 2024-09-30.